Ascensia Diabetes Care earns FDA clearance for new glucose monitoring system

Ascensia Diabetes Care received clearance from the Food and Drug Administration to market its Countour Next One blood glucose monitoring system.

Advertisement

The system includes a blood glucose smart meter, which can connect to an app on a patient’s mobile device to store and analyze blood glucose measurements, according to the report.

“We believe the future of healthcare lies in connecting points of care,” Robert Schumm, head of Ascensia Diabetes Care U.S., said in a company news release. “The first step in that journey for diabetes is to provide a connected system, which can add value for people living with diabetes.”

Parsippany, N.J.-based Ascensia Diabetes Care expects the Countour Next One Blood Glucose Monitoring System to hit the market in early 2017.

More articles on supply chain:

Texas Blood Center in desperate need of O-negative blood
5 trends on the growing role of digitization in supply chain
Novo Nordisk, Sanofi to battle for sales with new combination diabetes drugs: 4 takeaways

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.